EyePoint Pharmaceuticals, Inc.
$4.48
-0.15 (-3.24%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -65.2%
- 3 Months
- -67.0%
- YTD
- -75.5%
- 1 Year
- -62.2%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 98.2%
- Largest decline max drawdown, since Aug 2025
- -76.2%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.29
Own EYPT?
See how EYPT contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.